PAREXEL International Corporation, a biopharmaceutical services company, provides a range of clinical research, medical communications, consulting, commercialization, and technology products and services to the pharmaceutical, biotechnology, and medical device industries worldwide. The company operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS), and Perceptive Informatics (Perceptive). The CRS segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, data management and biostatistics, epidemiology and health economics/outcomes research, clinical logistics, and clinical pharmacology, as well as related medical advisory, patient recruitment, and investigator site services. This segment also manages various aspects of clinical trials, including study and protocol design; case report form design; paper or electronic questionnaires designed for use in clinical research; site and investigator recruitment; patient enrollment; study monitoring and data collection; data analysis; report writing; and medical services. The PCMS segment provides technical expertise and advice in various areas comprising drug development, regulatory affairs, product pricing and reimbursement, and GMP compliance; market development, product development, and targeted communications services in support of product launch. In addition, its consultants identify alternatives and propose solutions to address clients? product development, registration, and commercialization issues. The Perceptive segment provides information technology solutions comprising medical imaging and systems integration services; ClinPhone RTSM, CTMS, and EDC products; Web-based portals; systems integration; and patient diary applications. PAREXEL International Corporation was founded in 1983 and is headquartered in Waltham, Massachusetts.